Fast Track designation has the goal of bringing new treatments to patients sooner. In granting Fast Track, the FDA recognized fibromyalgia as a "serious condition," which shows the recognition ...
Fibromyalgia, the chronic pain condition that plagues approximately ten million Americans is in need of new drug treatment options. The existing approved drugs on the market often aren't enough.